OncoSil Medical Limited (OSL.AX)
AUD 0.0
(-20.0%)
AUD 0.0
(-20.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 1.98 Million AUD | 24.36% |
| 2023 | 1.59 Million AUD | -16.41% |
| 2022 | 1.9 Million AUD | -22.3% |
| 2021 | 2.45 Million AUD | 13.69% |
| 2020 | 2.15 Million AUD | 117.33% |
| 2019 | 993.21 Thousand AUD | -42.51% |
| 2018 | 1.72 Million AUD | 3.45% |
| 2017 | 1.67 Million AUD | 53.74% |
| 2016 | 1.08 Million AUD | 143.73% |
| 2015 | 445.69 Thousand AUD | 269.19% |
| 2014 | 120.72 Thousand AUD | -37.43% |
| 2013 | 192.95 Thousand AUD | 373.07% |
| 2012 | 40.78 Thousand AUD | -65.11% |
| 2011 | 116.88 Thousand AUD | -69.32% |
| 2010 | 380.94 Thousand AUD | -59.73% |
| 2009 | 945.93 Thousand AUD | -54.52% |
| 2008 | 2.07 Million AUD | -10.44% |
| 2007 | 2.32 Million AUD | -14.85% |
| 2006 | 2.72 Million AUD | 5699.18% |
| 2005 | 47.02 Thousand AUD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 2.35 Million AUD | 0.0% |
| 2024 Q4 | 1.98 Million AUD | 0.0% |
| 2024 FY | 1.76 Million AUD | 10.88% |
| 2023 FY | 1.59 Million AUD | -16.41% |
| 2023 Q4 | 1.59 Million AUD | 0.0% |
| 2023 Q2 | 1.86 Million AUD | 0.0% |
| 2022 FY | 1.9 Million AUD | -22.3% |
| 2022 Q2 | 1.67 Million AUD | 0.0% |
| 2022 Q4 | 1.9 Million AUD | 0.0% |
| 2021 Q2 | 1.99 Million AUD | 0.0% |
| 2021 Q4 | 2.45 Million AUD | 0.0% |
| 2021 FY | 2.45 Million AUD | 13.69% |
| 2020 FY | 2.15 Million AUD | 117.33% |
| 2020 Q4 | 2.15 Million AUD | 0.0% |
| 2020 Q2 | 1.14 Million AUD | 0.0% |
| 2019 Q4 | 993.21 Thousand AUD | 0.0% |
| 2019 FY | 993.21 Thousand AUD | -42.51% |
| 2019 Q2 | 1.78 Million AUD | 0.0% |
| 2018 Q4 | 1.72 Million AUD | 0.0% |
| 2018 Q2 | 1.72 Million AUD | 0.0% |
| 2018 FY | 1.72 Million AUD | 3.45% |
| 2017 Q4 | 1.67 Million AUD | 0.0% |
| 2017 FY | 1.67 Million AUD | 53.74% |
| 2017 Q2 | 315.45 Thousand AUD | 0.0% |
| 2016 Q4 | 1.08 Million AUD | 0.0% |
| 2016 FY | 1.08 Million AUD | 143.73% |
| 2016 Q2 | 839.92 Thousand AUD | 0.0% |
| 2015 Q2 | 466.25 Thousand AUD | 0.0% |
| 2015 FY | 445.69 Thousand AUD | 269.19% |
| 2015 Q4 | 445.69 Thousand AUD | 0.0% |
| 2014 Q2 | 209.51 Thousand AUD | 0.0% |
| 2014 FY | 120.72 Thousand AUD | -37.43% |
| 2014 Q4 | 120.72 Thousand AUD | 0.0% |
| 2013 Q2 | 43.69 Thousand AUD | 0.0% |
| 2013 FY | 192.95 Thousand AUD | 373.07% |
| 2013 Q3 | 192.95 Thousand AUD | 341.59% |
| 2013 Q4 | 192.95 Thousand AUD | 0.0% |
| 2013 Q1 | 43.69 Thousand AUD | 7.13% |
| 2012 FY | 40.78 Thousand AUD | -65.11% |
| 2012 Q4 | 40.78 Thousand AUD | 0.0% |
| 2011 FY | 116.88 Thousand AUD | -69.32% |
| 2011 Q4 | 116.88 Thousand AUD | 0.0% |
| 2010 FY | 380.94 Thousand AUD | -59.73% |
| 2010 Q4 | 380.94 Thousand AUD | 0.0% |
| 2009 Q4 | 945.93 Thousand AUD | 0.0% |
| 2009 FY | 945.93 Thousand AUD | -54.52% |
| 2008 FY | 2.07 Million AUD | -10.44% |
| 2008 Q4 | 2.07 Million AUD | 0.0% |
| 2007 Q4 | 2.32 Million AUD | 0.0% |
| 2007 FY | 2.32 Million AUD | -14.85% |
| 2006 FY | 2.72 Million AUD | 5699.18% |
| 2006 Q4 | 2.72 Million AUD | 0.0% |
| 2005 FY | 47.02 Thousand AUD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| 4DMedical Limited | 49.08 Million AUD | 95.962% |
| Adherium Limited | 3.4 Million AUD | 41.822% |
| Aroa Biosurgery Limited | 14.77 Million AUD | 86.589% |
| Atomo Diagnostics Limited | 1.29 Million AUD | -53.122% |
| Anteris Technologies Ltd | 17.03 Million AUD | 88.368% |
| Control Bionics Limited | 2.75 Million AUD | 28.178% |
| CardieX Limited | 8.56 Million AUD | 76.852% |
| Compumedics Limited | 22.14 Million AUD | 91.051% |
| Cochlear Limited | 904.6 Million AUD | 99.781% |
| CleanSpace Holdings Limited | 6.94 Million AUD | 71.481% |
| Cyclopharm Limited | 13.65 Million AUD | 85.485% |
| EMVision Medical Devices Ltd | 5.45 Million AUD | 63.671% |
| Nova Eye Medical Limited | 8.55 Million AUD | 76.824% |
| HeraMED Limited | 1.5 Million AUD | -31.612% |
| Imricor Medical Systems, Inc. | 25 Million AUD | 92.073% |
| ImpediMed Limited | 6.24 Million AUD | 68.253% |
| InhaleRx Limited | 911.41 Thousand AUD | -117.464% |
| LBT Innovations Limited | 5.5 Million AUD | 64.016% |
| Micro-X Limited | 12.63 Million AUD | 84.312% |
| Neurotech International Limited | 314.69 Thousand AUD | -529.806% |
| PolyNovo Limited | 37.04 Million AUD | 94.649% |
| Respiri Limited | 3.55 Million AUD | 44.232% |
| SomnoMed Limited | 24.78 Million AUD | 92.002% |
| Universal Biosensors, Inc. | 10.61 Million AUD | 81.324% |
| Uscom Limited | 2.07 Million AUD | 4.417% |
| Visioneering Technologies, Inc. | 2.76 Million AUD | 28.368% |